Expression of the plasminogen activator system in the human vascular wall.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Atherosclerosis

• Publication date

  2000-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0021-9150(99)00441-4PMID 10996335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.

  1998cited by this paper
• DETAILED LOCALIZATION OF TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR MRNA EXPRESSION AND ANTIGEN IN ATHEROSCLEROTIC PLAQUE ON HUMAN CORONARY ARTERY

  1998cited by this paper
• Urokinase but Not Tissue Plasminogen Activator Mediates Arterial Neointima Formation in Mice

  1997cited by this paper
• Relation of plaque lipid composition and morphology to the stability of human aortic plaques.

  1997cited by this paper
• The unstable atheroma.

  1997cited by this paper
• Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice.

  1997cited by this paper
• Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice.

  1997cited by this paper
• Inhibitors of fibrinolysis are elevated in atherosclerotic plaque.

  1996cited by this paper
• Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury.

  1995cited by this paper
• Plasminogen activator expression in human atherosclerotic lesions.

  1995cited by this paper
• Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animals.

  1995cited by this paper
• Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a price.

  1993cited by this paper
• The Role of Plasminogen Activation in Smooth Muscle Cell Migration after Arterial Injury

  1992cited by this paper
• Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

  1992cited by this paper
• Regulation of PAI-1 gene expression

  1991cited by this paper
• Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery.

  1990cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease

  1983cited by this paper
• Fibrinolytic Activity in Human Atherosclerotic Coronary Arteries

  1967cited by this paper
• The histological localisation of fibrinolysin activator.

  1959cited by this paper
• The biological significance of fibrinolysis.

  1956cited by this paper
• AMAUROSIS, FOLLOWING SUPPRESSED FEELINGS or PASSION.

  1836cited by this paper

• uPAR deficiency triggers TGFβ1-mediated fibrotic remodeling in a cardiac perivascular-like microenvironment.

  2026cites this paper
• Perfluorooctane sulfonate aggravates intimal hyperplasia and atherosclerosis by promoting phenotypic switching of smooth muscle cells via ERK/tPA pathway.

  2025cites this paper
• Insight on the cellular and molecular basis of blood vessel formation: A specific focus on tumor targets and therapy

  2023cites this paper
• The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients

  2022cites this paper
• Could targeting the macrophage urokinase-type plasminogen activator receptor be a bullseye for PET imaging of atherosclerotic plaque inflammation?

  2022cites this paper
• Circulating Biomarkers for Laboratory Diagnostics of Atherosclerosis—Literature Review

  2022cites this paper
• Review of cadmium exposure and smoking‐independent effects on atherosclerotic cardiovascular disease in the general population

  2021cites this paper
• Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer

  2020cites this paper
• Endothelial Dysfunction and Hypertension.

  2016cites this paper
• Polo-Like Kinase 1 and Smooth Muscle Cells in Coronary Artery Bypass Conduits and Coronary Arteries Following Angioplasty

  2016cites this paper
• What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers

  2015cites this paper
• inflammatory cardiovascular diseases Human neutrophil peptides : a novel potential mediator of

  2014cites this paper
• Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia?

  2014cites this paper
• Adipocytes derived fibrinolytic components in peritoneum — a pilot study

  2012cites this paper
• The PAI‐1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women

  2012cites this paper
• Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.

  2011cites this paper
• Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.

  2011cites this paper
• Urokinase-type plasminogen activator receptor is associated with the development of adipose tissue

  2010cites this paper
• Funktion des fibrinolytischen Systems im Nervensystem und intravasale Fibrinolyse

  2010cites this paper
• Plasmin induces apoptosis of aortic valvular myofibroblasts

  2010cites this paper
• ETUDE DES EFFETS DE L'EXTRAIT DE CARTILAGE DE REQUIN ET DU TLN-4601 SUR LE GLIOBLASTOME CHEZ LA SOURIS GR ^ ACE AUX TECHNOLOGIES TRANSCRIPTOMIQUES ET PROTEOMIQUES

  2010cites this paper
• Effects of a stable prostacyclin analogue beraprost sodium on VEGF and PAI-1 gene expression in vascular smooth muscle cells.

  2009cites this paper
• The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.

  2009cites this paper
• The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitus.

  2009cites this paper
• Are vitamin D receptor activators useful for the treatment of thrombosis?

  2009cites this paper
• Quantification of plasminogen activator inhibitor type 1 in the aortic wall.

  2009cites this paper
• Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.

  2009cites this paper
• Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.

  2008cites this paper
• "Linking proteolysis to lipids".

  2008cites this paper
• Title : The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitus

  2008cites this paper
• Endothelial Dysfunction: From Molecular Mechanisms to Measurement, Clinical Implications, and Therapeutic Opportunities

  2008cites this paper
• Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis.

  2008cites this paper
• Factor Seven Activating Protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques.

  2008cites this paper
• The absence of uPAR attenuates insulin-induced vascular smooth muscle cell migration and proliferation.

  2008cites this paper
• Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.

  2007cites this paper
• The effects of vitronectin at sites of myocardial ischemia and infarction

  2007cites this paper
• PATTERNS OF KINASE ACTIVATION INDUCED BY INJURY IN THE MURINE FEMORAL ARTERY

  2007cites this paper
• Tyk2 mediates effects of urokinase on human vascular smooth muscle cell growth.

  2007cites this paper
• Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells.

  2006cites this paper
• Serial Changes in Markers Measuring Coagulation, Fibrinolysis, and Vasoactivity in Patients with Ischemic Stroke

  2006cites this paper
• Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice Integrative

  2005cites this paper
• Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice

  2005cites this paper
• Lysophosphatidylcholine induces tPA gene expression through CRE-dependent mechanism.

  2005cites this paper
• Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice

  2005cites this paper
• Evaluation of Urokinase-Type Plasminogen Activator and Its Receptor in Neointima of Polyester Vascular Grafts

  2005cites this paper
• Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans

  2005cites this paper
• Use of a fibrin preparation in the engineering of a vascular graft model.

  2004cites this paper
• Differences in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-12 Transcript Levels Among Carotid Atherosclerotic Plaques With Different Histopathological Characteristics

  2004cites this paper
• Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions

  2004cites this paper
• NF1 Regulatory Element Functions as a Repressor of Tissue Plasminogen Activator Expression

  2004cites this paper
• Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages.

  2004cites this paper
• Laser Microdissection-based Analysis of mRNA Expression in Human Coronary Arteries with Intimal Thickening

  2004cites this paper
• Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.

  2004cites this paper
• NF 1 Regulatory Element Functions as a Repressor of Tissue Plasminogen Activator Expression

  2004cites this paper
• Reduced beta3-endonexin levels are associated with enhanced urokinase-type plasminogen activator receptor expression in ApoE-/- mice.

  2004cites this paper
• Pericellular plasmin induces smooth muscle cell anoikis

  2003cites this paper
• Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression.

  2003cites this paper
• Astrocyte regulation of human brain capillary endothelial fibrinolysis.

  2003cites this paper
• Low‐density lipoproteins induce the polar secretion of PAI‐1 by endothelial cells in culture

  2003cites this paper
• Plasminogen activator inhibitor activity is associated with raised lactate levels after cardiac surgery with cardiopulmonary bypass*

  2003cites this paper
• High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study

  2003cites this paper
• The 4G/5G-polymorphism in the PAI-1 gene is not associated with markers of atherosclerosis in male smokers.

  2002cites this paper
• Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.

  2002cites this paper
• Remnant lipoproteins induce endothelial plasminogen activator inhibitor-1.

  2001cites this paper
• Multiple organ dysfunction syndrome in patients with severe sepsis: more than just inflammation

  2001cites this paper
• Lighting up cancer aggressiveness: targeting the urokinase plasminogen activator receptor for intraoperative optical imaging

  year unknowncites this paper